Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Cimzia (certolizumab pegol) is a medication given as an injection for the treatment of adults who have any of the following conditions:
Cimzia comes in single-dose vials that contain 200 mg lyophilized powder or a single-dose prefilled syringes that contain 200 mg/mL of solution.
Fact Table | |
---|---|
Formula | C2154H3458N562O673S6 (for the Fab fragment) |
License | FDA approved |
Bioavailability | 80% (subcutaneous) |
Legal status | Prescription only |
Chemical Name | Certolizumab Pegol |
Elimination half-life | Approximately 14 days |
Dosage (Strength) | 200 mg/mL |
Pregnancy | Consult a healthcare provider; generally considered low risk |
Brands | Cimzia |
Protein binding | Not significantly bound |
PubChem CID | 16720913 |
MedlinePlus | a608034 |
ChEBI | 71167 |
ATC code | L04AB05 |
DrugBank | DB08905 |
KEGG | D06582 |
Routes of administration | Subcutaneous |
Cimiza injection should be used as your healthcare provider has instructed. He or she will decide on a treatment plan for you depending on the condition you have. A healthcare professional should teach you or your caregiver on the appropriate storage, preparation, administration, and disposal of Cimzia.
Cimiza should be injected subcutaneously (underneath the skin) in the thigh or abdomen. Be sure to rotate injection sites with each administration.
For more information regarding the use of Cimzia, refer to the medication guide that accompanies your prescription. You may refer any questions or concerns to your healthcare provider or pharmacist.
Do not reuse or share needles and syringes with others.
Certolizumab pegol is the active ingredient in Cimzia.
Lactic acid, polysorbate, and sucrose are the inactive ingredients in the lyophilized powder. Water for Injection is also used for mixing.
Sodium acetate, sodium chloride, and Water for Injection are the inactive ingredients in the prefilled syringes.
Cimzia should not be given to patients who are seriously allergic to any of its ingredients.
Cimzia side effects include but are not limited to upper respiratory tract infection, rash, and urinary tract infection. Inform your healthcare provider of any bothersome or persistent side effects that develop.
Here, you can buy Cimzia!
Cimzia. Smyrna, GA: UCB, Inc.; 2022.